Published in Oncotarget on August 02, 2016
Global cancer statistics, 2012. CA Cancer J Clin (2015) 53.52
Akt stimulates aerobic glycolysis in cancer cells. Cancer Res (2004) 9.35
Biomarkers for epithelial-mesenchymal transitions. J Clin Invest (2009) 8.76
mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H(+)-ATPase. Science (2011) 7.55
Vacuolar ATPases: rotary proton pumps in physiology and pathophysiology. Nat Rev Mol Cell Biol (2007) 6.86
Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth. Sci Signal (2009) 5.57
The vacuolar (H+)-ATPases--nature's most versatile proton pumps. Nat Rev Mol Cell Biol (2002) 5.19
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci U S A (2010) 4.97
MAP kinases and cell migration. J Cell Sci (2004) 4.46
bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis. Cancer Res (1995) 2.56
Function, structure and regulation of the vacuolar (H+)-ATPases. Arch Biochem Biophys (2008) 1.68
Phosphatidylinositol 3-kinase-mediated effects of glucose on vacuolar H+-ATPase assembly, translocation, and acidification of intracellular compartments in renal epithelial cells. Mol Cell Biol (2005) 1.62
Epidermal growth factor inhibits the growth of TE8 esophageal cancer cells through the activation of STAT1. J Gastroenterol (2002) 1.54
The growth and metastasis of human hepatocellular carcinoma xenografts are inhibited by small interfering RNA targeting to the subunit ATP6L of proton pump. Cancer Res (2005) 1.36
JMJD5 regulates PKM2 nuclear translocation and reprograms HIF-1α-mediated glucose metabolism. Proc Natl Acad Sci U S A (2013) 1.34
The glycolytic enzyme aldolase mediates assembly, expression, and activity of vacuolar H+-ATPase. J Biol Chem (2003) 1.33
FAK overexpression is correlated with tumour invasiveness and lymph node metastasis in oesophageal squamous cell carcinoma. Br J Cancer (2003) 1.32
LDHA is necessary for the tumorigenicity of esophageal squamous cell carcinoma. Tumour Biol (2012) 1.21
Vacuolar H+ ATPase expression and activity is required for Rab27B-dependent invasive growth and metastasis of breast cancer. Int J Cancer (2013) 1.01
S6 kinase 2 deficiency enhances ketone body production and increases peroxisome proliferator-activated receptor alpha activity in the liver. Hepatology (2012) 0.99
Pyruvate kinase M2 is highly correlated with the differentiation and the prognosis of esophageal squamous cell cancer. Dis Esophagus (2013) 0.97
Oncogene pathway activation in mammary tumors dictates FDG-PET uptake. Cancer Res (2014) 0.97
Rapid analysis of glycolytic and oxidative substrate flux of cancer cells in a microplate. PLoS One (2014) 0.91
Relationship between glucose transporter, hexokinase and FDG-PET in esophageal cancer. Hepatogastroenterology (2005) 0.91
Vacuolar ATPase 'a2' isoform exhibits distinct cell surface accumulation and modulates matrix metalloproteinase activity in ovarian cancer. Oncotarget (2015) 0.90
Expression patterns of three regulation enzymes in glycolysis in esophageal squamous cell carcinoma: association with survival. Med Oncol (2014) 0.89
The vacuolar H+ ATPase is a novel therapeutic target for glioblastoma. Oncotarget (2015) 0.89
Prognostic significance and function of phosphorylated ribosomal protein S6 in esophageal squamous cell carcinoma. Mod Pathol (2012) 0.88
Proton pump inhibitors (PPIs) impact on tumour cell survival, metastatic potential and chemotherapy resistance, and affect expression of resistance-relevant miRNAs in esophageal cancer. J Exp Clin Cancer Res (2014) 0.87
Silencing of atp6v1c1 prevents breast cancer growth and bone metastasis. Int J Biol Sci (2013) 0.87
V-ATPase inhibition regulates anoikis resistance and metastasis of cancer cells. Mol Cancer Ther (2014) 0.87
Vacuolar H(+)-ATPase signaling pathway in cancer. Curr Protein Pept Sci (2012) 0.85
Clinicopathologic significance and function of mammalian target of rapamycin activation in esophageal squamous cell carcinoma. Hum Pathol (2012) 0.83
Systematic review of patient-reported outcome measures in the surgical treatment of patients with esophageal cancer. Dis Esophagus (2015) 0.83
IGF1 regulates PKM2 function through Akt phosphorylation. Cell Cycle (2015) 0.82
S6K1 controls pancreatic β cell size independently of intrauterine growth restriction. J Clin Invest (2015) 0.81
Expression and role of V1A subunit of V-ATPases in gastric cancer cells. Int J Clin Oncol (2015) 0.79
Both high expression of pyruvate kinase M2 and vascular endothelial growth factor-C predicts poorer prognosis in human breast cancer. Int J Clin Exp Pathol (2015) 0.78
V-ATPase: a master effector of E2F1-mediated lysosomal trafficking, mTORC1 activation and autophagy. Oncotarget (2015) 0.77
Regulation of V-ATPase assembly and function of V-ATPases in tumor cell invasiveness. Biochim Biophys Acta (2016) 0.77